Company: SUPN
Filing Date: 2025-05-06
Form Type: 10-Q
Source: 0001356576-25-000033
Chunk: 32

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-05-06
Form: 10-Q
Item: Part II, Item 2
Chunk 32
---
), (iv) Condensed Consolidated Balance Sheets, (v) Condensed Consolidated Statements of Changes in Stockholders' Equity, (vi) Condensed Consolidated Statements of Cash Flows, and (vii) the Notes to Condensed Consolidated Financial Statements, tagged in summary and detail.104The cover page of the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, formatted in Inline XBRL (included with the Exhibit 101 attachments).

_______________________________________________________________________________ 

36

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.SUPERNUS PHARMACEUTICALS, INC.DATED: May 6, 2025By:/s/ Jack A. KhattarJack A. KhattarPresident and Chief Executive OfficerDATED: May 6, 2025By:/s/ Timothy C. DecTimothy C. DecSenior Vice-President and Chief Financial Officer

37